Published in Surgery on October 01, 2008
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? Surgery (2015) 1.66
Multimodal management of neuroendocrine liver metastases. HPB (Oxford) (2010) 1.21
A multimodal approach to the management of neuroendocrine tumour liver metastases. Int J Hepatol (2012) 0.94
Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor. World J Surg Oncol (2011) 0.86
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. Am J Clin Pathol (2015) 0.83
Primary Neuroendocrine Tumor of Liver (Rare Tumor of Liver). Iran J Cancer Prev (2015) 0.80
Adjuvant intraoperative post-dissectional tumor bed chemotherapy-A novel approach in treating midgut neuroendocrine tumors. J Gastrointest Oncol (2015) 0.78
Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia. Medicine (Baltimore) (2015) 0.78
Surgical treatment of neuroendocrine liver metastases. Int J Hepatol (2012) 0.77
Aace/Ace disease state clinical review: diagnosis and management of midgut carcinoids. Endocr Pract (2015) 0.76
Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies. Gland Surg (2014) 0.76
Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies. J Am Coll Surg (2012) 0.75
Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011. Curr Oncol (2012) 0.75
Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors. Surgery (2016) 0.75
Ectopic Cushing's syndrome due to a mesenteric neuroendocrine tumour. Ann R Coll Surg Engl (2012) 0.75
Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab (2005) 4.07
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas (2010) 3.00
Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.71
Bowel obstruction following appendectomy: what is the true incidence? Ann Surg (2009) 2.50
Bile duct injuries associated with laparoscopic cholecystectomy: timing of repair and long-term outcomes. Arch Surg (2010) 2.26
Postoperative complications following surgery for rectal cancer. Ann Surg (2010) 2.23
A pathologic re-review of follicular thyroid neoplasms: the impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma. Surgery (2008) 2.21
Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol (2006) 1.95
A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol (2009) 1.84
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59
Management of perforation after endoscopic retrograde cholangiopancreatography (ERCP): a population-based review. HPB (Oxford) (2006) 1.56
Predicting in-hospital mortality in patients undergoing complex gastrointestinal surgery: determining the optimal risk adjustment method. Arch Surg (2011) 1.54
Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiol Biomarkers Prev (2010) 1.51
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg (2005) 1.50
High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses. J Clin Hypertens (Greenwich) (2014) 1.45
ACS-NSQIP has the potential to create an HPB-NSQIP option. HPB (Oxford) (2009) 1.44
Dramatic innovations in modern surgical subspecialties. Can J Surg (2010) 1.40
Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.40
Primary thyroid lymphomas. Curr Treat Options Oncol (2004) 1.32
AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference. Ann Surg Oncol (2009) 1.29
Wound protectors reduce surgical site infection: a meta-analysis of randomized controlled trials. Ann Surg (2012) 1.21
Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study. Cancer (2008) 1.18
Utilization of thyroidectomy for benign disease in the United States: a 15-year population-based study. Am J Surg (2011) 1.13
Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery (2002) 1.10
Effect of ambient air pollution on the incidence of appendicitis. CMAJ (2009) 1.10
Effect of noise on auditory processing in the operating room. J Am Coll Surg (2013) 1.08
An evidence-based approach to the treatment of thyroid lymphoma. World J Surg (2007) 1.08
Comparison of stapled versus handsewn loop ileostomy closure: a meta-analysis. J Gastrointest Surg (2007) 1.07
Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol (2007) 1.07
Improvement in the accuracy of reporting key prognostic and anatomic findings during thyroidectomy by using a novel Web-based synoptic operative reporting system. Surgery (2009) 1.06
Morbidity and mortality following multivisceral resections in complex hepatic and pancreatic surgery. J Gastrointest Surg (2007) 1.06
Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy. HPB (Oxford) (2010) 1.04
Serum metabolomic profile as a means to distinguish stage of colorectal cancer. Genome Med (2012) 1.04
Impact of surgeon training on outcomes after resective hepatic surgery. Ann Surg Oncol (2008) 1.04
Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid). AJR Am J Roentgenol (2015) 1.03
Clinical manifestations of tension pneumothorax: protocol for a systematic review and meta-analysis. Syst Rev (2014) 1.02
Identification of prognostic inflammatory factors in colorectal liver metastases. BMC Cancer (2014) 1.02
Morbidity and mortality following colorectal surgery in patients with end-stage renal failure: a population-based study. Dis Colon Rectum (2010) 1.00
A review of thyroid cancer with intermediate differentiation. J Surg Oncol (2004) 1.00
Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Variable interpretation of adrenal vein sampling. Int Urol Nephrol (2008) 0.99
Outcome of laparoscopic splenectomy with preoperative splenic artery embolization for massive splenomegaly. Surg Endosc (2010) 0.99
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC Cancer (2004) 0.99
Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease. Arch Surg (2011) 0.99
The impact of country and culture on end-of-life care for injured patients: results from an international survey. J Trauma (2010) 0.99
Adrenal venous sampling in primary hyperaldosteronism: comparison of radiographic with biochemical success and the clinical decision-making with "less than ideal" testing. Surgery (2006) 0.99
Intermittent hepatic vein--total vascular exclusion during liver resection: anatomic and clinical studies. J Gastrointest Surg (2005) 0.98
Septic thrombophlebitis of the inferior mesenteric vein from sigmoid diverticulitis. J Am Coll Surg (2003) 0.97
What symptom improvement can be expected after operation for primary hyperparathyroidism? World J Surg (2009) 0.96
Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol (2007) 0.96
Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ (2006) 0.95
Recent trends of hepatic resection in Canada: 1995-2004. J Gastrointest Surg (2008) 0.94
131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors. World J Surg (2004) 0.92
Hospital performance reports based on severity adjusted mortality rates in patients with cirrhosis depend on the method of risk adjustment . Ann Hepatol (2012) 0.92
Training in Hepatopancreatobiliary Surgery: Assessment of the Hepatopancreatobiliary Surgery Workforce in North America. Ann Surg (2015) 0.91
Acute care surgery: the impact of an acute care surgery service on assessment, flow, and disposition in the emergency department. Am J Surg (2012) 0.90
Elective resection of colon cancer by high-volume surgeons is associated with decreased morbidity and mortality. J Gastrointest Surg (2011) 0.90
The utility of the harmonic scalpel in selective neck dissection: a prospective, randomized trial. Otolaryngol Head Neck Surg (2011) 0.90
Well differentiated intrahepatic cholangiocarcinoma in the setting of biliary papillomatosis: a case report and review of the literature. Can J Gastroenterol (2005) 0.90
AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma. HPB (Oxford) (2010) 0.89
The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms. Surgery (2004) 0.89
Impact of regional lymph node evaluation in staging patients with periampullary tumors. Ann Surg Oncol (2007) 0.88
Clinical Presentation of Patients With Tension Pneumothorax: A Systematic Review. Ann Surg (2015) 0.87
Admission base deficit and lactate levels in Canadian patients with blunt trauma: are they useful markers of mortality? J Trauma Acute Care Surg (2012) 0.86
Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature. J Surg Oncol (2002) 0.86
Water-jet dissection for parenchymal division during hepatectomy. HPB (Oxford) (2006) 0.86
Ambient ozone concentrations and the risk of perforated and nonperforated appendicitis: a multicity case-crossover study. Environ Health Perspect (2013) 0.85
A decade of experience with injuries to the gallbladder. J Trauma Manag Outcomes (2010) 0.85
Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature. J Surg Oncol (2002) 0.85
A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases. BMC Cancer (2009) 0.85
Rupture and intra-peritoneal bleeding of a hepatocellular carcinoma after a transarterial chemoembolization procedure: a case report. Cases J (2009) 0.85
Primary colorectal lymphoma-clinical outcomes in a population-based series. J Gastrointest Surg (2011) 0.85
Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series. Am J Surg (2005) 0.85
Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients. Can J Surg (2009) 0.84
Biochemical assessment of niacin deficiency among carcinoid cancer patients. Am J Gastroenterol (2005) 0.84
Functional results and quality of life after tracheal resection for locally invasive thyroid cancer. Am J Surg (2003) 0.84
Measuring and reporting on quality in health care: a framework and road map for improving care. J Surg Oncol (2009) 0.83
Survival after hepatic resection: impact of surgeon training on long-term outcome. Can J Surg (2013) 0.83
Neurofibroma of the porta hepatis. J Hepatobiliary Pancreat Surg (2008) 0.83
Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review. HPB (Oxford) (2013) 0.83
Complex hepatic surgery aided by a 1.5-tesla moveable magnetic resonance imaging system. Am J Surg (2006) 0.83
Hospitalization for uncomplicated hypertension: an ambulatory care sensitive condition. Can J Cardiol (2013) 0.82
Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC. Int J Hepatol (2011) 0.82
Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg Clin North Am (2004) 0.82
American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. Thyroid (2012) 0.82
Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4. Endocr Pathol (2007) 0.82
Open transgastric debridement and internal drainage of symptomatic non-infected walled-off pancreatic necrosis. HPB (Oxford) (2011) 0.81
The consensus statement on mixed martial arts: emotion, not evidence-based. Can J Surg (2011) 0.81
Hepatic resection in Canada: rates and geographic variation. Can J Surg (2009) 0.81
Perioperative supplemental oxygen in colorectal patients: a meta-analysis. J Surg Res (2009) 0.81
Pancreatic fistulae: are we making progress? J Hepatobiliary Pancreat Surg (2008) 0.81
Disparities in the surgical treatment of colorectal liver metastases. J Natl Med Assoc (2013) 0.81
Mortality following liver resection in US medicare patients: does the presence of a liver transplant program affect outcome? J Surg Oncol (2007) 0.81
A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable. BMC Endocr Disord (2014) 0.81
Hepatic vein injury during laparoscopic cholecystectomy: the unappreciated proximity of the middle hepatic vein to the gallbladder bed. J Gastrointest Surg (2006) 0.81
Role of imaging in the preoperative staging of small bowel neuroendocrine tumors. J Am Coll Surg (2010) 0.80
The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada. Can J Gastroenterol (2011) 0.80